GeneDx Holdings Corp. (WGS)
Data as of , from SEC Form 4 filings.
See up to 3 months of WGS. The 7-day demo opens the 1M and 3M ranges and puts WGS on your watchlist.
Start 7-day demoLatest WGS insider trades
About GeneDx Holdings Corp. (WGS)
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
- STAMFORD, CT
- 1,300
- 2021
- XNAS
WGS Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 13 | 19,578 | $1.84M |
| Option exercise | 12 | 73,638 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
WGS insider transactions (Form 4)
12585 Form 4 filings on record, the earliest from Oct 17, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Open-market sale | Class A Common Stock | 1,280 | $86.75 footnote F3 | $111K | ||
| Option exercise | Restricted Stock Unit | 2,462 | $0.00 | - | ||
| Option exercise | Class A Common Stock | 2,462 | $0.00 footnote F1 | - | ||
| ||||||
| Option exercise | Class A Common Stock | 6,546 | $0.00 footnote F1 | - | ||
| Open-market sale | Class A Common Stock | 3,678 | $86.75 footnote F3 | $319K | ||
| Option exercise | Restricted Stock Unit | 6,546 | $0.00 | - | ||
| ||||||
| Grant or award | Class A Common Stock | 1,986 | $88.11 | $175K | ||
| Grant or award | Class A Common Stock | 3,404 | $88.11 | $300K | ||
| Open-market purchase | Class A Common Stock | 47,623 | $80.55 footnote F9 | $3.84M | ||
| Open-market purchase | Class A Common Stock | 60,892 | $81.37 footnote F10 | $4.95M | ||
| Open-market purchase | Class A Common Stock | 29,236 | $82.06 footnote F11 | $2.40M | ||
| Open-market purchase | Class A Common Stock | 19,686 | $70.34 footnote F1 | $1.38M | ||
| Open-market purchase | Class A Common Stock | 8,439 | $71.48 footnote F4 | $603K | ||
| Open-market purchase | Class A Common Stock | 200 | $72.00 | $14K | ||
| Open-market purchase | Class A Common Stock | 921 | $75.66 footnote F5 | $70K | ||
| Open-market purchase | Class A Common Stock | 249 | $75.99 footnote F6 | $19K | ||
| Open-market purchase | Class A Common Stock | 304 | $77.96 footnote F7 | $24K | ||
| Open-market purchase | Class A Common Stock | 1,971 | $78.91 footnote F8 | $156K | ||
| ||||||
| Grant or award | Restricted Stock Unit | 10,430 | $0.00 | - | ||
| Open-market sale | Class A Common Stock | 1,424 | $77.63 footnote F3 | $111K | ||
| Open-market sale | Class A Common Stock | 2,543 | $78.61 footnote F4 | $200K | ||
| Open-market sale | Class A Common Stock | 2,220 | $79.25 footnote F5 | $176K | ||
| Grant or award | Restricted Stock Unit | 10,865 | $0.00 | - | ||
| Grant or award | Class A Common Stock | 15,262 | $0.00 | - | ||
| ||||||
| Grant or award | Class A Common Stock | 47,684 | $0.00 | - | ||
| Open-market sale | Class A Common Stock | 5,861 | $77.63 footnote F3 | $455K | ||
| Open-market sale | Class A Common Stock | 10,465 | $78.61 footnote F4 | $823K | ||
| Open-market sale | Class A Common Stock | 9,133 | $79.25 footnote F5 | $724K | ||
| Grant or award | Restricted Stock Unit | 40,418 | $0.00 | - | ||
| ||||||
| Option exercise | Class A Common Stock | 718 | $0.00 footnote F1 | - | ||
| Open-market sale | Class A Common Stock | 287 | $77.52 footnote F3 | $22K | ||
| Option exercise | Restricted Stock Unit | 718 | $0.00 | - | ||
| ||||||
| Open-market sale | Class A Common Stock | 779 | $83.04 footnote F2 | $65K | ||
| Open-market sale | Class A Common Stock | 1,425 | $83.83 footnote F3 | $119K | ||
| Open-market sale | Class A Common Stock | 1,034 | $84.93 footnote F4 | $88K | ||
| Open-market sale | Class A Common Stock | 623 | $86.35 footnote F5 | $54K | ||
| Open-market sale | Class A Common Stock | 1,572 | $87.66 footnote F6 | $138K | ||
| Open-market sale | Class A Common Stock | 328 | $88.66 footnote F7 | $29K | ||
| Open-market sale | Class A Common Stock | 100 | $90.45 footnote F8 | $9K | ||
| Open-market sale | Class A Common Stock | 100 | $91.92 | $9K | ||
| ||||||
| Option exercise | Class A Common Stock | 9,374 | $0.00 footnote F1 | - | ||
| Open-market sale | Class A Common Stock | 93 | $96.77 footnote F3 | $9K | ||
| Open-market sale | Class A Common Stock | 492 | $98.61 footnote F4 | $49K | ||
| Open-market sale | Class A Common Stock | 1,662 | $99.40 footnote F5 | $165K | ||
| Open-market sale | Class A Common Stock | 1,166 | $100.31 footnote F6 | $117K | ||
| Option exercise | Restricted Stock Unit | 9,374 | $0.00 | - | ||
| ||||||
| Option exercise | Class A Common Stock | 754 | $0.00 footnote F1 | - | ||
| Open-market sale | Class A Common Stock | 315 | $94.00 | $30K | ||
| Open-market sale | Class A Common Stock | 2 | $92.06 | $184 | ||
| Option exercise | Restricted Stock Unit | 754 | $0.00 | - | ||
| ||||||
| Option exercise | Class A Common Stock | 3,874 | $0.00 footnote F1 | - | ||
| Open-market sale | Class A Common Stock | 1,653 | $94.00 footnote F3 | $155K | ||
| Option exercise | Restricted Stock Unit | 3,874 | $0.00 | - | ||
| ||||||
| Option exercise | Class A Common Stock | 717 | $0.00 footnote F1 | - | ||
| Open-market sale | Class A Common Stock | 377 | $162.54 footnote F4 | $61K | ||
| Option exercise | Restricted Stock Unit | 717 | $0.00 | - | ||
| ||||||
| Joshua Ruch | Open-market sale | Class A Common Stock | 201 | $158.40 footnote F1 | $32K | |
| Joshua Ruch | Open-market sale | Class A Common Stock | 625 | $159.28 footnote F3 | $100K | |
| Joshua Ruch | Open-market sale | Class A Common Stock | 889 | $160.45 footnote F4 | $143K | |
| Joshua Ruch | Open-market sale | Class A Common Stock | 1,117 | $161.16 footnote F5 | $180K | |
| Joshua Ruch | Open-market sale | Class A Common Stock | 72 | $162.04 footnote F6 | $12K | |
| Joshua Ruch | Open-market sale | Class A Common Stock | 407 | $158.40 footnote F1 | $64K | |
| Joshua Ruch | Open-market sale | Class A Common Stock | 1,268 | $159.28 footnote F3 | $202K | |
| Joshua Ruch | Open-market sale | Class A Common Stock | 1,805 | $160.45 footnote F4 | $290K | |
| Joshua Ruch | Open-market sale | Class A Common Stock | 2,268 | $161.16 footnote F5 | $366K | |
| Joshua Ruch | Open-market sale | Class A Common Stock | 147 | $162.04 footnote F6 | $24K | |
| Joshua Ruch | Open-market sale | Class A Common Stock | 2,016 | $158.40 footnote F1 | $319K | |
| Joshua Ruch | Open-market sale | Class A Common Stock | 6,279 | $159.28 footnote F3 | $1.00M | |
| Joshua Ruch | Open-market sale | Class A Common Stock | 8,944 | $160.45 footnote F4 | $1.44M | |
| Joshua Ruch | Open-market sale | Class A Common Stock | 11,234 | $161.16 footnote F5 | $1.81M | |
| Joshua Ruch | Open-market sale | Class A Common Stock | 728 | $162.04 footnote F6 | $118K | |
| ||||||
| Option exercise | Class A Common Stock | 753 | $0.00 footnote F1 | - | ||
| Open-market sale | Class A Common Stock | 388 | $136.54 | $53K | ||
| Option exercise | Restricted Stock Unit | 753 | $0.00 | - | ||
| ||||||
| Option exercise | Class A Common Stock | 3,874 | $0.00 footnote F1 | - | ||
| Open-market sale | Class A Common Stock | 2,154 | $136.54 | $294K | ||
| Open-market sale | Class A Common Stock | 4 | $136.75 | $547 | ||
| Option exercise | Restricted Stock Unit | 3,874 | $0.00 | - | ||
| ||||||
| Option exercise | Class A Common Stock | 1,246 | $32.67 | $41K | ||
| Open-market sale | Class A Common Stock | 344 | $105.24 | $36K | ||
| Open-market sale | Class A Common Stock | 387 | $106.86 | $41K | ||
| Open-market sale | Class A Common Stock | 2,715 | $107.68 | $292K | ||
| Open-market sale | Class A Common Stock | 2,152 | $108.67 | $234K | ||
| Open-market sale | Class A Common Stock | 421 | $110.05 | $46K | ||
| Open-market sale | Class A Common Stock | 520 | $111.93 | $58K | ||
| Open-market sale | Class A Common Stock | 70 | $113.68 | $8K | ||
| Option exercise | Employee Stock Option (Right to Buy) | 1,246 | $0.00 | - | ||
| Open-market sale | Class A Common Stock | 606 | $105.10 | $64K | ||
| Open-market sale | Class A Common Stock | 1,092 | $106.69 | $117K | ||
| Open-market sale | Class A Common Stock | 4,462 | $107.61 | $480K | ||
| Open-market sale | Class A Common Stock | 5,163 | $108.55 | $560K | ||
| Open-market sale | Class A Common Stock | 554 | $109.13 | $60K | ||
| Open-market sale | Class A Common Stock | 200 | $110.23 | $22K | ||
| Open-market sale | Class A Common Stock | 645 | $111.84 | $72K | ||
| Open-market sale | Class A Common Stock | 136 | $113.68 | $15K | ||
| Thomas Fuchs | Grant or award | Restricted Stock Unit | 3,438 | $0.00 | - | |
| Option exercise | Class A Common Stock | 7,197 | $0.00 | - | ||
| Option exercise | Class A Common Stock | 18,750 | $0.00 | - | ||
| Open-market sale | Class A Common Stock | 10,501 | $121.47 | $1.28M | ||
| Option exercise | Restricted Stock Unit | 18,750 | $0.00 | - | ||
| Option exercise | Class A Common Stock | 2,462 | $0.00 | - | ||
| Open-market sale | Class A Common Stock | 1,266 | $128.05 | $162K | ||
| Open-market sale | Class A Common Stock | 6 | $129.09 | $775 | ||
| Option exercise | Restricted Stock Unit | 2,462 | $0.00 | - | ||
| Option exercise | Class A Common Stock | 6,546 | $0.00 | - | ||
| Open-market sale | Class A Common Stock | 3,639 | $128.05 | $466K | ||
| Open-market sale | Class A Common Stock | 18 | $129.08 | $2K | ||
| Option exercise | Restricted Stock Unit | 6,546 | $0.00 | - | ||
| Option exercise | Class A Common Stock | 717 | $0.00 | - | ||
| Open-market sale | Class A Common Stock | 378 | $125.81 | $48K | ||
| Option exercise | Restricted Stock Unit | 717 | $0.00 | - | ||
| Jason Ryan | Open-market sale | Class A Common Stock | 8,818 | $125.07 | $1.10M | |
| Jason Ryan | Open-market sale | Class A Common Stock | 8,969 | $126.15 | $1.13M | |
| Jason Ryan | Open-market sale | Class A Common Stock | 5,443 | $127.44 | $694K | |
| Jason Ryan | Open-market sale | Class A Common Stock | 3,452 | $128.04 | $442K | |
| Jason Ryan | Open-market sale | Class A Common Stock | 9,890 | $129.59 | $1.28M | |
| Jason Ryan | Open-market sale | Class A Common Stock | 1,500 | $130.01 | $195K | |
| Jason Ryan | Open-market sale | Class A Common Stock | 1,150 | $129.65 | $149K | |
| Casdin Capital, LLC - Director | Open-market sale | Class A Common Stock | 500,000 | $120.90 | $60.45M | |
| Option exercise | Class A Common Stock | 753 | $0.00 | - | ||
| Open-market sale | Class A Common Stock | 388 | $105.31 | $41K | ||
| Option exercise | Restricted Stock Unit | 753 | $0.00 | - | ||
| Option exercise | Class A Common Stock | 3,874 | $0.00 | - | ||
| Open-market sale | Class A Common Stock | 2,154 | $105.31 | $227K | ||
| Option exercise | Restricted Stock Unit | 3,874 | $0.00 | - | ||
Recent WGS Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Katherine Stueland | Officer, Director | 14,243 | $1.21M | View on EDGAR | |
| Kevin Feeley | Officer | 5,410 | $459K | View on EDGAR | |
| - | - | - | - | View on EDGAR |
WGS insider trading FAQ
What is the latest insider trade for WGS?
GeneDx Holdings Corp. (WGS) had 6 insider filings in the last 90 days, with the most recent on 2026-09-18. The full record for WGS runs to 85 Form 4 filings, the earliest from 2024-10-17. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying WGS stock?
No insider purchases of WGS were filed in the last 90 days. 42 purchases are on record for this company.
How many insiders are selling WGS stock?
13 insider sales of WGS were filed in the last 90 days, totaling $1.84M.
Where can I see WGS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects WGS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Katherine Stueland view on EDGAR
- - Kevin Feeley view on EDGAR
- - Thomas Fuchs view on EDGAR
- - Katherine Stueland view on EDGAR
- - Kevin Feeley view on EDGAR
- - Kevin Feeley view on EDGAR
- - Mark A. Gardner view on EDGAR
- - Jason Ryan view on EDGAR
- - Joshua Ruch view on EDGAR
- - Richard C. Pfenniger Jr. view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where WGS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow WGS with a 7-day demo
- WGS on your watchlist
- Every WGS Form 4 filing on record
- Up to 3 months of WGS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive